Platelet Transfusion
Publication Date: November 28, 2017
Key Points
Key Points
Prophylactic platelet transfusion should be administered to patients with thrombocytopenia resulting from impaired bone marrow function to reduce the risk of hemorrhage when the platelet count falls below a predefined threshold level.
Recommended thresholds for prophylactic platelet transfusion are provided for patients with hematologic malignacies or solid tumors, and those undergoing hematopoietic stem cell transplantation or invasive procedures.
Guidance is also provided regarding the production of platelet products, prevention of Rh alloimmunization, and management of refractoriness to platelet transfusion.
Recommended thresholds for prophylactic platelet transfusion are provided for patients with hematologic malignacies or solid tumors, and those undergoing hematopoietic stem cell transplantation or invasive procedures.
Guidance is also provided regarding the production of platelet products, prevention of Rh alloimmunization, and management of refractoriness to platelet transfusion.
Treatment
Treatment
...paration of Platelet ProductsPlatelets for tr...
...revention of Rh AlloimmunizationUPDAT...
...UPDATED. The incidence of alloantibody-mediated r...
...ctic vs Therapeutic Platelet TransfusionPr...
...let Transfusion Threshold in Patients with Hemat...
...Transfusion Threshold in the Setting of Hema...
...ransfusion in Patients with Chronic, Stable...
...t Transfusion Threshold in Patients With Solid Tum...
...Count at which Surgical or Invasive Procedu...
...nitoring for Refractoriness to Platelet T...
...ng Refractoriness to Platelet Transfu...